personalized medicine: a new era in endocrinology

New Era in Medicine

A new paradigm for biospecimen banking in the personalized medicine era.

Banking of high-quality, appropriately consented human tissue is crucial for the understanding of disease pathogenesis and translation of such knowledge into improvements in patient care. Traditionally, tissue banking has been thought of as primarily an academic research activity, but tissue and biospecimen banking is increasingly assuming clinical importance, especially with the advent of gene...

The Treatment of Metastatic Non-Small Cell Lung Cancer in a New Era of Personalized Medicine

Lung cancer is the leading cause of cancer-related mortality in Canada (1) and around the world. Non-small cell lung cancer (NSCLC) is the most frequent form of lung cancer, accounting for approximately 87% of cases and the majority of these are metastatic at the time of presentation (2, 3). We have reached a plateau (4, 5) with different systemic chemotherapies, specifically platinum-based, wh...

Precision Medicine: The new era in medicine

Precision medicine, also known as stratified medicine or personal-ized medicine, aims to better target intervention to the individual, maximize benefit and minimize harm. Enthusiasm for the prospect of precision medicine has grown significantly in the last few years. There has been increasing interest in two streams of development in precision medicine. First is the integration of electronic me...

Role of personalized medicine in cardiovascular disease: A narrative review

Cardiovascular diseases are the leading cause of mortality each year. Both environmental and genetic risk factors significantly influence the incidence and progression of these diseases. In recent decades, with the development of genetics and genome-determining tools, different genes have been found associated with numerous diseases. Determining these genes helps us to suggest a more effective ...

Inherited thrombocytopenias in the era of personalized medicine.